ResearcherTohoku UniversityNo recent work listed
Shinichi Fukushige
Matched on ORCID iD 0009-0005-7097-8164; OpenAlex author ID A5069384475. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers
Papers 7
- TWIST1 is a prognostic factor for neoadjuvant chemotherapy for patients with resectable pancreatic cancer: a preliminary study. Co-author DOI 10.1007/s00595-023-02655-3↗
- Long Non-Coding RNAs Associated with Mitogen-Activated Protein Kinase in Human Pancreatic Cancer. First author DOI 10.3390/cancers15010303↗
- NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second promoter in human gastrointestinal cancers. Co-author DOI 10.1016/j.bbrc.2017.01.055↗
- Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers. Co-author DOI 10.1016/j.canlet.2012.03.022↗
- Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. Co-author DOI 10.1016/j.bbrc.2013.10.010↗
- S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells. Co-author DOI 10.1016/j.bbrc.2012.10.048↗
- Identification of epigenetically silenced genes in human pancreatic cancer by a novel method "microarray coupled with methyl-CpG targeted transcriptional activ… Last author DOI 10.1016/j.bbrc.2011.06.121↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuriko Saiki · 5 shared papers, 2012–2023 · strength 0.51
- Paper TWIST1 is a prognostic factor for neoadjuvant chemotherapy for patients with resectable pancreatic cancer: a preliminar… DOI 10.1007/s00595-023-02655-3↗
- Paper Long Non-Coding RNAs Associated with Mitogen-Activated Protein Kinase in Human Pancreatic Cancer. DOI 10.3390/cancers15010303↗
- Paper NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second prom… DOI 10.1016/j.bbrc.2017.01.055↗
- Akira Horii · 6 shared papers, 2011–2023 · strength 0.43
- Paper TWIST1 is a prognostic factor for neoadjuvant chemotherapy for patients with resectable pancreatic cancer: a preliminar… DOI 10.1007/s00595-023-02655-3↗
- Paper Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers. DOI 10.1016/j.canlet.2012.03.022↗
- Paper NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second prom… DOI 10.1016/j.bbrc.2017.01.055↗
- Michiaki Unno · 4 shared papers, 2011–2023 · strength 0.32
- Paper TWIST1 is a prognostic factor for neoadjuvant chemotherapy for patients with resectable pancreatic cancer: a preliminar… DOI 10.1007/s00595-023-02655-3↗
- Paper NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second prom… DOI 10.1016/j.bbrc.2017.01.055↗
- Paper Identification of epigenetically silenced genes in human pancreatic cancer by a novel method "microarray coupled with m… DOI 10.1016/j.bbrc.2011.06.121↗
- Fuyuhiko Motoi · 4 shared papers, 2011–2023 · strength 0.32
- Paper TWIST1 is a prognostic factor for neoadjuvant chemotherapy for patients with resectable pancreatic cancer: a preliminar… DOI 10.1007/s00595-023-02655-3↗
- Paper NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second prom… DOI 10.1016/j.bbrc.2017.01.055↗
- Paper Identification of epigenetically silenced genes in human pancreatic cancer by a novel method "microarray coupled with m… DOI 10.1016/j.bbrc.2011.06.121↗
- Sho Fujiwara · 1 shared paper, 2023 · strength 0.19
- Tomohiko Ishikawa · 1 shared paper, 2023 · strength 0.19
- Katsuya Hirose · 1 shared paper, 2023 · strength 0.19
- Toru Furukawa · 1 shared paper, 2023 · strength 0.19
- Makoto Sunamura · 4 shared papers, 2011–2017 · strength 0.15
- Paper NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second prom… DOI 10.1016/j.bbrc.2017.01.055↗
- Paper Identification of epigenetically silenced genes in human pancreatic cancer by a novel method "microarray coupled with m… DOI 10.1016/j.bbrc.2011.06.121↗
- Paper Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. DOI 10.1016/j.bbrc.2013.10.010↗
- Akihiro Yamamura · 2 shared papers, 2013–2017 · strength 0.09
- Shinichi Egawa · 2 shared papers, 2011–2013 · strength 0.06
- Hiroki Nagase · 2 shared papers, 2012–2013 · strength 0.06
- Hideyuki Shimizu · 1 shared paper, 2011 · strength 0.03
- Kazuhiro Morishita · 1 shared paper, 2013 · strength 0.03
- Hitoshi Sekine · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.